|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.75 USD | +5.78% |
|
+15.81% | +15.17% |
| 06-26 | European Medicines Agency Panel Backs Label Expansion for Incyte's Opzelura | MT |
| 06-26 | UBS Adjusts Price Target on Incyte to $113 From $103, Maintains Neutral Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +5.78% | +15.81% | +16.86% | +25.97% | +15.17% | +66.37% | +84.42% | +31.00% | +57.03% | 22.73B | |
| +2.06% | +3.76% | +0.82% | -14.21% | -18.00% | +21.48% | -11.62% | +14.96% | +91.18% | 64.39B | |
| +0.74% | +3.52% | +5.90% | +2.58% | +8.34% | +51.88% | +225.16% | +197.95% | +315.19% | 56.12B | |
| -3.10% | +34.30% | +34.30% | +34.30% | +34.30% | +34.30% | +34.30% | +34.30% | - | 40.54B | |
| -2.36% | -1.25% | +15.73% | -19.78% | -33.47% | -50.98% | -58.84% | -59.71% | +5.56% | 37.98B | |
| +6.97% | +9.89% | +9.68% | +17.51% | +22.75% | +71.34% | -23.65% | -37.91% | -3.82% | 31.89B | |
| +12.59% | +5.18% | +41.29% | +35.73% | +128.11% | +147.68% | -44.25% | -69.41% | - | 26.69B | |
| -1.25% | -1.31% | -4.81% | -12.11% | -1.44% | -2.84% | +151.34% | -15.85% | - | 16.66B | |
| -0.81% | +5.91% | +5.00% | +20.90% | +40.08% | +63.81% | +125.65% | +214.89% | +379.38% | 16.6B | |
| +0.79% | +5.99% | +5.72% | +0.77% | -8.17% | +56.58% | +331.18% | +16.20% | - | 13.76B | |
| +1.83% | -3.52% | +3.05% | +54.57% | +32.32% | +133.81% | +189.88% | +228.80% | +3,059.08% | 12.44B | |
| -8.40% | -2.83% | -11.13% | -9.84% | -23.58% | -9.72% | +717.86% | +395.43% | +6,789.14% | 12B | |
| +2.88% | +7.88% | +12.64% | +8.98% | -0.72% | +6.94% | -35.68% | -30.42% | -20.92% | 11.4B | |
| +3.42% | +6.95% | +21.40% | +51.70% | +50.99% | +168.04% | +222.63% | +450.10% | - | 10.97B | |
| +0.42% | +0.26% | -5.80% | +4.56% | -14.71% | -11.66% | -19.20% | -59.73% | -51.00% | 6.34B | |
| +3.30% | +14.02% | +55.59% | +124.21% | +214.75% | +177.87% | +446.17% | -18.54% | - | 6.22B | |
| -6.83% | +3.26% | -2.94% | -15.96% | +0.92% | +12.60% | +261.93% | +194.26% | - | 5.46B | |
| -0.93% | -1.97% | -14.74% | -33.65% | -34.20% | -29.91% | +111.57% | +56.90% | +112.13% | 5.07B | |
| -4.30% | -7.95% | -23.21% | -34.21% | -41.54% | -57.21% | -60.45% | -79.09% | - | 4.88B | |
| -5.15% | -5.17% | +1.11% | -12.88% | -21.01% | +0.26% | +45.92% | -53.72% | - | 4.7B | |
| Average | +0.38% | +2.66% | +8.32% | +11.46% | +17.54% | +42.53% | +134.72% | +70.52% | +975.72% | 20.34B | |
| Weighted average by Cap. | +1.36% | +3.65% | +11.41% | +9.03% | +14.47% | +42.78% | +92.83% | +60.86% | +544.27% |
- Stock Market
- Stocks
- INCY Stock
- Sector Incyte Corporation
Select your edition
All financial news and data tailored to specific country editions
